This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Chinese Academy of Medical Sciences, Guangdong Provincial Hospital of Tcm, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine. Active years: 2023.
Company Filing History:
1 out of 129 
1 out of 2 
1 out of 2 Years Active: 2023
Title: Inventor Profile: Xiaowan Wang from Guangdong, CN
Introduction: Xiaowan Wang is a notable inventor based in Guangdong, China, recognized for her significant contributions to the field of anti-cancer research. With one patent to her name, she has developed innovative compounds aimed at fighting cancerous cells while minimizing toxicity to normal cells.
Latest Patents: Xiaowan Wang's latest patent, titled "Triptolide acrylate, preparation method therefor and use thereof," presents a new triptolide derivative. This invention outlines a preparation method for the compound and explores its medical use in the development of anti-cancer drugs. The triptolide acrylate showcases impressive anti-cancer activity and, following in-vivo animal experiments, has proven effective in inhibiting tumor growth. Moreover, numerous in-vitro experiments indicate that it significantly increases the protein expression of p53, promotes apoptosis in tumor cells, and effectively inhibits tumor cell growth while also demonstrating the ability to reduce cancer cell metastasis. Notably, the compound exhibits lower toxicity to normal cells compared to triptolide.
Career Highlights: Throughout her career, Xiaowan Wang has contributed to reputable institutions, most notably the Guangdong Provincial Hospital of Traditional Chinese Medicine and The Second Affiliated Hospital of Guangzhou University of Chinese Medicine. Her work in these esteemed hospitals has provided her with a strong foundation in medical research and clinical applications.
Collaborations: In her professional journey, Xiaowan has collaborated with fellow researchers, including Bo Liu and Xianzhang Huang. These collaborations have fostered an environment of innovation and shared knowledge, further enhancing her research capabilities and contributions to cancer treatment therapies.
Conclusion: Xiaowan Wang is a pioneering inventor making strides in anti-cancer research. Her patented innovation, triptolide acrylate, represents a promising advancement in the development of effective cancer therapies with reduced toxicity to normal cells. As research continues in this domain, Wang's contributions will likely influence future developments in cancer treatment methodologies.